封面
市場調查報告書
商品編碼
1974950

全球高通量篩檢市場規模、佔有率、趨勢和成長分析報告(2026-2034)

Global High-Throughput Screening Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 137 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

高通量篩檢市場預計將從 2025 年的 353.8 億美元成長到 2034 年的 855.6 億美元,2026 年至 2034 年的複合年成長率為 10.31%。

隨著製藥和生技公司致力於加速藥物研發進程,全球高通量篩檢市場持續擴張。高通量篩檢技術使研究人員能夠快速且有效率地測試數千種化合物,從而縮短早期藥物研發所需的時間。日益複雜的疾病也推動了企業對更快、更精準的篩檢解決方案的投資。

關鍵成長要素包括研發投入的增加和自動化技術的進步。機器人技術、數據分析和改進的檢測技術正在提高篩檢的準確性和效率。學術機構和受託研究機構也透過採用先進的篩檢平台為市場成長做出貢獻。此外,製藥公司與技術供應商之間的合作也在推動該領域的創新。

市場前景依然樂觀,持續的技術創新不斷提升篩檢的速度和成本效益。人們對個人化醫療和標靶治療日益成長的興趣將進一步推動對高通量解決方案的需求。隨著藥物研發管線的擴展和研究更加數據驅動,高通量篩檢將繼續成為現代藥物開發至關重要的工具。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球高通量篩檢市場:依產品與服務分類

  • 市場分析、洞察與預測
  • 裝置
  • 消耗品
  • 軟體和服務

第5章:全球高通量篩檢市場:依技術分類

  • 市場分析、洞察與預測
  • 基於細胞的檢測
  • 晶片實驗室技術
  • 其他

第6章 全球高通量篩檢市場:依應用分類

  • 市場分析、洞察與預測
  • 藥物發現
  • 生化篩檢
  • 其他

第7章 全球高通量篩檢市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Bio-Rad Laboratories Inc
    • Biotek Instruments Inc
    • Axxam SPA
    • Agilent Technologies Inc
    • Corning Incorporated
    • PerkinElmer Inc
    • Merck Group KGaA
    • Aurora Biomed Inc
    • Danaher Corporation
    • Thermo Fisher Scientific Inc
簡介目錄
Product Code: VMR112110818

The High-Throughput Screening Market size is expected to reach USD 85.56 Billion in 2034 from USD 35.38 Billion (2025) growing at a CAGR of 10.31% during 2026-2034.

The Global High-Throughput Screening Market is expanding as pharmaceutical and biotechnology companies focus on accelerating drug discovery processes. High-throughput screening technologies allow researchers to test thousands of compounds quickly and efficiently, reducing the time required for early-stage drug development. The increasing prevalence of complex diseases is pushing companies to invest in faster and more precise screening solutions.

Major growth drivers include rising research and development spending and advancements in automation technologies. Robotics, data analytics, and improved assay technologies are enhancing screening accuracy and efficiency. Academic research institutes and contract research organizations are also contributing to market growth by adopting advanced screening platforms. Additionally, collaborations between pharmaceutical companies and technology providers are supporting innovation in this field.

Future prospects for the market remain promising, with continuous technological advancements improving screening speed and cost-effectiveness. The growing interest in personalized medicine and targeted therapies will further increase demand for high-throughput solutions. As drug pipelines expand and research becomes more data-driven, high-throughput screening will remain a critical tool in modern pharmaceutical development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Services

  • Instrument
  • Consumables
  • Software & Services

By Technology

  • Cell based assays
  • Lab-on-chip technology
  • Others

By Application

  • Drug discovery
  • Biochemical screening
  • Others

COMPANIES PROFILED

  • BioRad Laboratories Inc, Biotek Instruments Inc, Axxam SpA, Agilent Technologies Inc, Corning Incorporated, PerkinElmer Inc, Merck Group KGaA, Aurora Biomed Inc, Danaher Corporation, Thermo Fisher Scientific Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HIGH-THROUGHPUT SCREENING MARKET: BY PRODUCT & SERVICES 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product & Services
  • 4.2. Instrument Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. Cell based assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Lab-on-chip technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HIGH-THROUGHPUT SCREENING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Drug discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Biochemical screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HIGH-THROUGHPUT SCREENING MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product & Services
    • 7.2.2 By Technology
    • 7.2.3 By Application
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product & Services
    • 7.3.2 By Technology
    • 7.3.3 By Application
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product & Services
    • 7.4.2 By Technology
    • 7.4.3 By Application
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product & Services
    • 7.5.2 By Technology
    • 7.5.3 By Application
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product & Services
    • 7.6.2 By Technology
    • 7.6.3 By Application
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HIGH-THROUGHPUT SCREENING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Bio-Rad Laboratories Inc
    • 9.2.2 Biotek Instruments Inc
    • 9.2.3 Axxam S.P.A
    • 9.2.4 Agilent Technologies Inc
    • 9.2.5 Corning Incorporated
    • 9.2.6 PerkinElmer Inc
    • 9.2.7 Merck Group KGaA
    • 9.2.8 Aurora Biomed Inc
    • 9.2.9 Danaher Corporation
    • 9.2.10 Thermo Fisher Scientific Inc